News Jounce set to make first biotech IPO of 2017 Massachusetts-based company will test the waters for biotech sector
News Circassia leads UK biotech funding success Three separate fund-raising rounds - headed by Circassia's £275 million placing and open offer - give a further indication of the revival in the
Oncology ASCO 2026: First to first line in HER-2 NSCLC, with Itziar C... At ASCO 2026, BI Global Head of Oncology Itziar Canamasas spoke with pharmaphorum about the company's ASCO data and broader oncology strategy.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
